{"id":"https://openalex.org/W2005285472","doi":"https://doi.org/10.1097/00001813-200603000-00011","title":"Anti-proliferative effect of peroxisome proliferator-activated receptor ?? agonists on human malignant melanoma cells in vitro","display_name":"Anti-proliferative effect of peroxisome proliferator-activated receptor ?? agonists on human malignant melanoma cells in vitro","alternate_titles":[],"publication_year":2006,"publication_date":"2006-02-20","ids":{"openalex":"https://openalex.org/W2005285472","doi":"https://doi.org/10.1097/00001813-200603000-00011","mag":"2005285472","pmid":"https://pubmed.ncbi.nlm.nih.gov/16520661"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-200603000-00011","doi":"https://doi.org/10.1097/00001813-200603000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200603000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005285472"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010951942","display_name":"Christian Freudlsperger","orcid":"https://orcid.org/0000-0002-4289-0457","observed_orcids":["https://orcid.org/0000-0002-4289-0457"]},"institutions":[{"id":"https://openalex.org/I159176309","display_name":"Universit\u00e4t Hamburg","ror":"https://ror.org/00g30e956","country_code":"DE","type":"education","lineage":["https://openalex.org/I159176309"]},{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christian Freudlsperger","raw_affiliation_strings":["Zentrum f\u00fcr Experimentelle Medizin, Institut f\u00fcr Anatomie II: Experimentelle Morphologie, Hamburg, Germany. c.freudlsperger@uke.uni-hamburg.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zentrum f\u00fcr Experimentelle Medizin, Institut f\u00fcr Anatomie II: Experimentelle Morphologie, Hamburg, Germany. c.freudlsperger@uke.uni-hamburg.de","institution_ids":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020075149","display_name":"Ingrid Moll","orcid":"https://orcid.org/0000-0003-4162-8112","observed_orcids":["https://orcid.org/0000-0003-4162-8112"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingrid Moll","raw_affiliation_strings":["Kopf- und Hautzentrum, Klinik f\u00fcr Dermatologie und Venerologie, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kopf- und Hautzentrum, Klinik f\u00fcr Dermatologie und Venerologie, Universit\u00e4tsklinikum Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062826138","display_name":"Udo Schumacher","orcid":"https://orcid.org/0000-0003-1494-5956","observed_orcids":["https://orcid.org/0000-0003-1494-5956"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Udo Schumacher","raw_affiliation_strings":["Zentrum f\u00fcr Experimentelle Medizin, Institut f\u00fcr Anatomie II: Experimentelle Morphologie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zentrum f\u00fcr Experimentelle Medizin, Institut f\u00fcr Anatomie II: Experimentelle Morphologie","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111494462","display_name":"Anka Thies","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anka Thies","raw_affiliation_strings":["Zentrum f\u00fcr Experimentelle Medizin, Institut f\u00fcr Anatomie II: Experimentelle Morphologie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zentrum f\u00fcr Experimentelle Medizin, Institut f\u00fcr Anatomie II: Experimentelle Morphologie","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5010951942"],"corresponding_institution_ids":["https://openalex.org/I159176309","https://openalex.org/I4210108711"],"apc_list":null,"apc_paid":null,"fwci":2.0927,"has_fulltext":false,"cited_by_count":45,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85898027,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"17","issue":"3","first_page":"325","last_page":"332"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.9200000166893005},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.9760000109672546},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9890000224113464},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cell-proliferation-inhibition","display_name":"cell proliferation inhibition","score":0.7590000033378601},{"id":"https://openalex.org/keywords/melanoma-cell-lines","display_name":"melanoma cell lines","score":0.7979999780654907},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.8619999885559082},{"id":"https://openalex.org/keywords/ciglitazone","display_name":"ciglitazone","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":1.0},{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ppargamma-expression","display_name":"PPAR\u03b3 expression","score":0.7509999871253967},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2780963305","wikidata":"https://www.wikidata.org/wiki/Q5119890","display_name":"Ciglitazone","level":4,"score":0.9405434131622314},{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.8965483903884888},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.7229663133621216},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.7222843170166016},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.6618174314498901},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5820746421813965},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5768988728523254},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.5515965819358826},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5379707217216492},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.501680850982666},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5004673004150391},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4906074106693268},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.46649786829948425},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.43692725896835327},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37450292706489563},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35357314348220825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30789121985435486},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09308463335037231},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.0},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003593","descriptor_name":"Cytoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-200603000-00011","doi":"https://doi.org/10.1097/00001813-200603000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200603000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:16520661","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16520661","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W12952247","https://openalex.org/W1482551393","https://openalex.org/W1586597239","https://openalex.org/W1589415602","https://openalex.org/W1925149569","https://openalex.org/W1966861485","https://openalex.org/W1971432398","https://openalex.org/W2000956332","https://openalex.org/W2003537519","https://openalex.org/W2004501846","https://openalex.org/W2009562082","https://openalex.org/W2014214643","https://openalex.org/W2031694725","https://openalex.org/W2032378607","https://openalex.org/W2032598681","https://openalex.org/W2047982128","https://openalex.org/W2052035619","https://openalex.org/W2058680827","https://openalex.org/W2066524854","https://openalex.org/W2073133082","https://openalex.org/W2078757355","https://openalex.org/W2082597621","https://openalex.org/W2083290248","https://openalex.org/W2089946893","https://openalex.org/W2091321756","https://openalex.org/W2091881323","https://openalex.org/W2097679250","https://openalex.org/W2121001769","https://openalex.org/W2122951893","https://openalex.org/W2128635872","https://openalex.org/W2130959723","https://openalex.org/W2147326561","https://openalex.org/W2150557496","https://openalex.org/W2167124143","https://openalex.org/W2171518012","https://openalex.org/W2333284976"],"related_works":["https://openalex.org/W1531230504","https://openalex.org/W2094795797","https://openalex.org/W2089946893","https://openalex.org/W2063064231","https://openalex.org/W7206873846","https://openalex.org/W2029212596","https://openalex.org/W2041732289","https://openalex.org/W2108575355","https://openalex.org/W2165422300","https://openalex.org/W2001052947"],"abstract_inverted_index":{"Malignant":[0],"melanoma":[1,61,69,191],"has":[2],"a":[3,76,113,125,198],"poor":[4],"reputation":[5],"for":[6,201],"early":[7],"spread":[8],"and":[9,52,92,105,144,195],"no":[10],"curative":[11],"treatment":[12,74],"is":[13],"yet":[14],"available.":[15],"As":[16,173],"peroxisome":[17],"proliferator-activated":[18],"receptor":[19],"gamma":[20],"(PPARgamma)":[21],"agonists":[22],"(glitazones)":[23],"have":[24,29,181],"recently":[25],"been":[26,182],"shown":[27],"to":[28,42,184],"growth-inhibiting":[30],"effects":[31,45],"on":[32,54,118],"different":[33,163],"cancer":[34],"lineages,":[35],"the":[36,44,55,87,133,151,162],"aim":[37],"of":[38,46,57,66,86,94,127,137,170,178,188],"this":[39],"study":[40],"was":[41,82,100,147],"analyze":[43],"four":[47,110],"glitazones":[48,111,180],"(rosiglitazone,":[49],"ciglitazone,":[50],"pioglitazone":[51],"troglitazone)":[53],"growth":[56,187],"six":[58,67,120],"human":[59,68,189],"malignant":[60,190],"cells":[62,192],"in":[63,96,150,158,193],"vitro.":[64],"Proliferation":[65],"cell":[70,89,98,121,138,164],"lines":[71,99,122,165],"under":[72],"glitazone":[73],"over":[75],"broad":[77],"concentration":[78,126],"range":[79],"(0.15-300":[80],"micromol/l)":[81],"assessed":[83],"by":[84,141,168],"means":[85],"XTT":[88],"proliferation":[90],"assay,":[91],"expression":[93,160],"PPARgamma":[95,146,159],"these":[97],"analyzed":[101],"using":[102],"both":[103],"immunohistochemical":[104],"molecular":[106],"biological":[107],"techniques.":[108],"All":[109],"showed":[112],"significant":[114],"dose-dependent":[115],"anti-proliferative":[116],"effect":[117],"all":[119],"starting":[123],"at":[124],"0.3":[128],"micromol/l,":[129],"with":[130],"ciglitazone":[131],"being":[132],"most":[134],"potent":[135],"inhibitor":[136],"growth,":[139],"followed":[140],"troglitazone,":[142],"rosiglitazone":[143],"pioglitazone.":[145],"predominantly":[148],"localized":[149],"cytoplasm;":[152],"however,":[153],"there":[154],"were":[155],"quantitative":[156],"differences":[157],"between":[161],"as":[166],"demonstrated":[167],"quantification":[169],"Western":[171],"blots.":[172],"an":[174],"already":[175],"approved":[176],"class":[177],"drugs,":[179],"found":[183],"significantly":[185],"inhibit":[186],"vitro":[194],"might":[196],"be":[197],"promising":[199],"tool":[200],"further":[202],"therapeutic":[203],"studies.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005285472","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
